CS438990A3 - Process for preparing novel derivatives of 1h,3h-pyrrolo-(1,2-c)thiazole-7-carboxamide - Google Patents

Process for preparing novel derivatives of 1h,3h-pyrrolo-(1,2-c)thiazole-7-carboxamide

Info

Publication number
CS438990A3
CS438990A3 CS904389A CS438990A CS438990A3 CS 438990 A3 CS438990 A3 CS 438990A3 CS 904389 A CS904389 A CS 904389A CS 438990 A CS438990 A CS 438990A CS 438990 A3 CS438990 A3 CS 438990A3
Authority
CS
Czechoslovakia
Prior art keywords
phenyl
alkyl
phenylalkyl
pyridyl
hydroxyalkyl
Prior art date
Application number
CS904389A
Other languages
English (en)
Inventor
Claude James
Daniel Lave
Francoise Soler
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of CS438990A3 publication Critical patent/CS438990A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CS904389A 1989-03-17 1990-03-15 Process for preparing novel derivatives of 1h,3h-pyrrolo-(1,2-c)thiazole-7-carboxamide CS438990A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903510A FR2644456B1 (fr) 1989-03-17 1989-03-17 Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
CS438990A3 true CS438990A3 (en) 1992-03-18

Family

ID=9379793

Family Applications (2)

Application Number Title Priority Date Filing Date
CS904389A CS438990A3 (en) 1989-03-17 1990-03-15 Process for preparing novel derivatives of 1h,3h-pyrrolo-(1,2-c)thiazole-7-carboxamide
CS901252A CS276785B6 (en) 1989-03-17 1990-03-15 PROCESS FOR PREPARING NOVEL DERIVATIVES OF 1H,3H-PYRROLO-(1,2-c)THIAZOLE-7-CARBOXAMIDE

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS901252A CS276785B6 (en) 1989-03-17 1990-03-15 PROCESS FOR PREPARING NOVEL DERIVATIVES OF 1H,3H-PYRROLO-(1,2-c)THIAZOLE-7-CARBOXAMIDE

Country Status (24)

Country Link
US (1) US5086051A (cs)
EP (1) EP0388309B1 (cs)
JP (1) JPH02289586A (cs)
KR (1) KR900014408A (cs)
AT (1) ATE102210T1 (cs)
BG (1) BG51159A3 (cs)
CA (1) CA2012343A1 (cs)
CS (2) CS438990A3 (cs)
DD (1) DD297822A5 (cs)
DE (1) DE69006872T2 (cs)
DK (1) DK0388309T3 (cs)
ES (1) ES2062432T3 (cs)
FI (1) FI92069C (cs)
FR (1) FR2644456B1 (cs)
IE (1) IE63313B1 (cs)
IL (1) IL93760A (cs)
MA (1) MA21771A1 (cs)
MX (1) MX26542A (cs)
NO (1) NO172392C (cs)
NZ (1) NZ232960A (cs)
PL (1) PL284321A1 (cs)
PT (1) PT93485B (cs)
TN (1) TNSN90030A1 (cs)
ZA (1) ZA902033B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW214545B (cs) * 1992-02-17 1993-10-11 Ciba Geigy Ag
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
DE69329550T2 (de) 1992-07-13 2001-05-31 Cytomed Inc 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
TW266206B (cs) * 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5891895A (en) * 1996-04-15 1999-04-06 Takeda Chemical Industries, Ltd. Hydroxypyridine derivatives their production and use
JP5169216B2 (ja) * 2005-08-19 2013-03-27 独立行政法人産業技術総合研究所 色可逆変化表示装置用電極体及びその製造方法、並びに色可逆変化表示装置及び色可逆変化調光装置
WO2009125434A2 (en) * 2008-04-07 2009-10-15 Cadila Healthcare Limited Oxime derivatives
WO2014192023A1 (en) * 2013-05-22 2014-12-04 Cadila Healthcare Limited Novel compounds suitable for the treatment of dyslipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CS276785B6 (en) 1992-08-12
DD297822A5 (de) 1992-01-23
FI92069B (fi) 1994-06-15
FR2644456A1 (fr) 1990-09-21
IE63313B1 (en) 1995-04-05
DE69006872D1 (de) 1994-04-07
PT93485A (pt) 1990-11-07
TNSN90030A1 (fr) 1991-03-05
ATE102210T1 (de) 1994-03-15
EP0388309A2 (fr) 1990-09-19
EP0388309B1 (fr) 1994-03-02
JPH02289586A (ja) 1990-11-29
CA2012343A1 (fr) 1990-09-17
IE900984L (en) 1990-09-17
NZ232960A (en) 1991-02-26
FR2644456B1 (fr) 1991-07-05
NO901237L (no) 1990-09-18
IL93760A0 (en) 1990-12-23
DK0388309T3 (da) 1994-04-11
PL284321A1 (en) 1991-07-29
DE69006872T2 (de) 1994-06-30
KR900014408A (ko) 1990-10-23
NO172392C (no) 1993-07-14
IL93760A (en) 1994-08-26
CS125290A3 (en) 1992-03-18
ZA902033B (en) 1990-12-28
FI92069C (fi) 1994-09-26
FI901325A0 (fi) 1990-03-16
US5086051A (en) 1992-02-04
ES2062432T3 (es) 1994-12-16
NO172392B (no) 1993-04-05
NO901237D0 (no) 1990-03-16
PT93485B (pt) 1996-02-29
MA21771A1 (fr) 1990-10-01
MX26542A (es) 1993-09-01
BG51159A3 (en) 1993-02-15
EP0388309A3 (fr) 1991-07-24

Similar Documents

Publication Publication Date Title
CS125290A3 (en) Process for preparing novel derivatives of 1h,3h-pyrrolo-(1,2-c)thiazole-7-carboxamide
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
IL55930A (en) Phenylalkoxydihydroxyoctahydrophenanthrenes,pharmaceutical compositions containing them and intermediates for their preparation
HU911091D0 (en) Process for the production of substituted azoles and medical preparations, containing them
PL285683A1 (en) Method of obtaining novel amines
ES479932A1 (es) Un procedimiento para la preparacion de derivados de amino- piridina.
YU43738B (en) Process for making 1,4-dihydropyridine
ES8204732A1 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
ES8600261A1 (es) Un compuesto fenoxi
BR8400549A (pt) Derivados e sais inertes de hidroxido de aminopiridinios e processos de preparacao;e composicao farmaceutica
ES8601210A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
ES8407059A1 (es) Procedimiento para la preparacion de un nuevo derivado del pirrolo ortocondensado
ES8407318A1 (es) Procedimiento de preparacion de derivados de piperacina.
ZA889285B (en) 2-amino-tetrahydro-isoquinoline derivatives and a process for the preparation thereof and pharmaceutical composition containing same
BG50610A3 (en) Method for the preparation of derivatives of 1h, 3h- pyrol (1, 2- c) thiazole- 7- carboxamide